Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

The characterization of IBF as a new selective dopamine D-2 receptor imaging agent

Journal Article · · Journal of Nuclear Medicine; (USA)
OSTI ID:7044803

The in vivo and in vitro studies of a new iodinated benzamide analog, (125I)IBF,5-iodo-7-N-((1-ethyl-2-pyrrolidinyl)methyl)carboxamido-2,3- dihydrobenzofuran as a potential central nervous system (CNS) D-2 dopamine receptor imaging agent were investigated. In vivo biodistribution of IBF in rat indicated that this agent concentrated in the striatum region and displayed a remarkably high target-to-nontarget ratio (striatum/cerebellum = 48 at 120 min post-injection). The in vitro binding studies suggested that IBF binds selectively to D-2 dopamine receptors with high affinity and low nonspecific binding (Kd = 0.106 +/- 0.015 nM, Bmax = 448 +/- 18.2 fmole/mg protein). Ex vivo autoradiography results in rats further confirmed the high uptake and retention of this agent in the basal ganglia region. The planar images of monkey brains (lateral view of the head) after i.v. injection of ({sup 123}I)IBF clearly demonstrated that D-2 dopamine receptors can be visualized. With the excellent in vivo stability to deiodination and high target-to-nontarget ratio, ({sup 123}I)IBF may be useful as a CNS D-2 dopamine receptor imaging agent for single photon emission computed tomography (SPECT) in humans.

OSTI ID:
7044803
Journal Information:
Journal of Nuclear Medicine; (USA), Journal Name: Journal of Nuclear Medicine; (USA) Vol. 31:5; ISSN 0161-5505; ISSN JNMEA
Country of Publication:
United States
Language:
English

Similar Records

Synthesis and characterization of iodobenzamide analogues: Potential D-2 dopamine receptor imaging agents
Journal Article · Sun Dec 31 23:00:00 EST 1989 · Journal of Medicinal Chemistry; (USA) · OSTI ID:7105468

In vitro and in vivo evaluation of (/sup 123/I)IBZM: a potential CNS D-2 dopamine receptor imaging agent
Journal Article · Sat Dec 31 23:00:00 EST 1988 · J. Nucl. Med.; (United States) · OSTI ID:6406676

Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- ((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Journal Article · Sun May 01 00:00:00 EDT 1988 · J. Med. Chem.; (United States) · OSTI ID:6970273